13F Holdings
中文EN

PASW Ping An Biomedical Co., Ltd. Annual reports only

Apparel & Other Finishd Prods of Fabrics & Similar Matl · Nasdaq · SEC CIK 1897532 · Reporting currency CNY

Financial factors as of 2025-09-30 (FY2025), by fiscal year; growth vs the previous fiscal year

Growth

TTM revenue YoY-61.0%
TTM net income YoY-899.0%
TTM EPS YoY-885.7%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin2.8%
Operating margin-43.1%
Net margin-37.6%
FCF margin—
EBITDA margin-43.0%

Returns

ROE-67.4%
ROA-20.5%
ROIC (approx.)-63.2%
Asset turnover0.55x

Leverage & solvency

Liabilities / assets33.9%
Debt / equity0.00x
Current ratio2.76x
Interest coverage-47.88x

Cash quality & payout

Operating cash flow / net income0.50x
Accruals ratio-10.2%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Annual Quarterly (none) Export CSV 🔒
Unit: CNY FY20252025-09-30FY20242024-09-30FY20232023-09-30
Income statement
Revenue34.15M87.62M82.56M
Cost of revenue33.20M82.21M78.32M
Gross profit949,5055.42M4.24M
SG&A expense6.01M4.99M3.27M
Operating income-14.70M-2,039612,481
Interest expense307,055705,2731.74M
Pretax income-14.68M-682,71641,686
Income tax1.86M-601,456-1.04M
Net income-12.83M-1.28M-993,937
EBITDA-14.70M8,200645,237
EPS (basic)-0.69-0.07-0.06
EPS (diluted)-0.69-0.07-0.06
Weighted avg. shares (diluted)18.48M18.00M18.00M
Balance sheet
Cash & equivalents1.17M130,923591,874
Receivables16.93M40.44M—
Inventory441,904127,296—
Current assets63.70M53.31M—
PP&E, net—5,585—
Total assets68.41M56.85M—
Current liabilities23.08M63.58M—
Short-term debt10.00M10.00M—
Total liabilities23.17M64.04M—
Shareholders' equity45.24M-7.19M-5.86M
Shares outstanding20.50M18.00M—
Cash flow statement
Operating cash flow-6.43M14.63M-6.08M
Investing cash flow015.00M-3.37M
Financing cash flow43.66M-30.09M8.87M
Depreciation & amortization5,58510,23932,756
Dividends paid—322,4129.60M

· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.

· Amounts are in the company's reporting currency, CNY, not USD; the site does no currency conversion.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.